STRS Ohio’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-16,838
Closed -$393K 2354
2021
Q1
$393K Hold
16,838
﹤0.01% 1649
2020
Q4
$315K Hold
16,838
﹤0.01% 1643
2020
Q3
$428K Hold
16,838
﹤0.01% 1417
2020
Q2
$486K Buy
+16,838
New +$988K ﹤0.01% 1330
2017
Q2
Sell
-638
Closed -$41K 1990
2017
Q1
$41K Hold
638
﹤0.01% 1792
2016
Q4
$59K Hold
638
﹤0.01% 1769
2016
Q3
$71K Sell
638
-25
-4% -$2.43K ﹤0.01% 1717
2016
Q2
$54K Buy
+663
New +$42.2K ﹤0.01% 1759

Other funds holding NERV

STRS Ohio's NERV Position: Q2 2021 in Review

STRS Ohio sold out of Minerva Neurosciences (NERV) in Q2 2021, closing a stake of 16,838 shares — an estimated $393K sold.

STRS Ohio first reported a position in NERV in Q2 2016 and held it in 8 quarters. The position peaked at $486K in Q2 2020. 68 funds tracked by Wall St. Rank hold NERV as of Q2 2021.

  • STRS Ohio reported no remaining Minerva Neurosciences position as of Q2 2021 after selling out during the quarter.
  • STRS Ohio sold 16,838 Minerva Neurosciences shares in Q2 2021, an estimated $393K.
  • STRS Ohio first reported a position in Minerva Neurosciences in Q2 2016 and held it in 8 quarters.
  • STRS Ohio's Minerva Neurosciences position peaked at $486K in Q2 2020.
  • 68 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.